OpenURL Connection Search

Select item for more details and to access through your institution.

Cost-effectiveness of basal insulin from a US health system perspective: comparative analyses of detemir, glargine, and NPH.
Published in:
2006
By:
- Valentine WJ;
- Palmer AJ;
- Erny-Albrecht KM;
- Ray JA;
- Cobden D;
- Foos V;
- Lurati FM;
- Roze S;
- Valentine, William J;
- Palmer, Andrew J;
- Erny-Albrecht, Katrina M;
- Ray, Joshua A;
- Cobden, David;
- Foos, Volker;
- Lurati, Fransisco M;
- Roze, Stéphane
Publication type:
journal article
PROactive 06: cost-effectiveness of pioglitazone in Type 2 diabetes in the UK.
Published in:
2007
By:
- Valentine WJ;
- Bottomley JM;
- Palmer AJ;
- Brändle M;
- Foos V;
- Williams R;
- Dormandy JA;
- Yates J;
- Tan MH;
- Massi-Benedetti M;
- PROactive Study Group
Publication type:
Journal Article
PROactive 06: cost-effectiveness of pioglitazone in Type 2 diabetes in the UK.
Published in:
Diabetic Medicine, 2007, v. 24, n. 9, p. 982, doi. 10.1111/j.1464-5491.2007.02188.x
By:
- Valentine, W. J.;
- Bottomley, J. M.;
- Palmer, A. J.;
- Brändle, M.;
- Foos, V.;
- Williams, R.;
- Dormandy, J. A.;
- Yates, J.;
- Tan, M. H.;
- Massi-Benedetti, M.
Publication type:
Article
Biphasic insulin aspart 70/30 vs. insulin glargine in insulin naïve type 2 diabetes patients: modelling the long-term health economic implications in a Swedish setting.
Published in:
2008
By:
- Goodall G;
- Jendle JH;
- Valentine WJ;
- Munro V;
- Brandt AB;
- Ray JA;
- Roze S;
- Foos V;
- Palmer AJ
Publication type:
Journal Article
Biphasic insulin aspart 70/30 vs. insulin glargine in insulin naïve type 2 diabetes patients: modelling the long-term health economic implications in a Swedish setting.
Published in:
International Journal of Clinical Practice, 2008, v. 62, n. 6, p. 869, doi. 10.1111/j.1742-1241.2008.01766.x
By:
- Goodall, G.;
- Jendle, J. H.;
- Valentine, W. J.;
- Munro, V.;
- Brandt, A. B.;
- Ray, J. A.;
- Roze, S.;
- Foos, V.;
- Palmer, A. J.
Publication type:
Article

Found: 5

Cost-effectiveness of basal insulin from a US health system perspective: comparative analyses of detemir, glargine, and NPH.

PROactive 06: cost-effectiveness of pioglitazone in Type 2 diabetes in the UK.

PROactive 06: cost-effectiveness of pioglitazone in Type 2 diabetes in the UK.

Biphasic insulin aspart 70/30 vs. insulin glargine in insulin naïve type 2 diabetes patients: modelling the long-term health economic implications in a Swedish setting.

Biphasic insulin aspart 70/30 vs. insulin glargine in insulin naïve type 2 diabetes patients: modelling the long-term health economic implications in a Swedish setting.